IDEXX Laboratories Valuation
| IX1 Stock | EUR 406.20 6.80 1.70% |
At this time, the firm appears to be overvalued. IDEXX Laboratories retains a regular Real Value of €341.21 per share. The prevalent price of the firm is €406.2. Our model calculates the value of IDEXX Laboratories from inspecting the firm fundamentals such as Return On Equity of 1.05, return on asset of 0.22, and Operating Margin of 0.27 % as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that IDEXX Laboratories' price fluctuation is very steady at this time. Calculation of the real value of IDEXX Laboratories is based on 3 months time horizon. Increasing IDEXX Laboratories' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the IDEXX stock is determined by what a typical buyer is willing to pay for full or partial control of IDEXX Laboratories. Since IDEXX Laboratories is currently traded on the exchange, buyers and sellers on that exchange determine the market value of IDEXX Stock. However, IDEXX Laboratories' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 406.2 | Real 341.21 | Hype 406.2 | Naive 411.04 |
The real value of IDEXX Stock, also known as its intrinsic value, is the underlying worth of IDEXX Laboratories Company, which is reflected in its stock price. It is based on IDEXX Laboratories' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of IDEXX Laboratories' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of IDEXX Laboratories helps investors to forecast how IDEXX stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of IDEXX Laboratories more accurately as focusing exclusively on IDEXX Laboratories' fundamentals will not take into account other important factors: IDEXX Laboratories Total Value Analysis
IDEXX Laboratories is currently estimated to have takeover price of 35.12 B with market capitalization of 37.22 B, debt of 694.39 M, and cash on hands of 116.62 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the IDEXX Laboratories fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
35.12 B | 37.22 B | 694.39 M | 116.62 M |
IDEXX Laboratories Investor Information
About 93.0% of the company shares are owned by institutional investors. The company recorded earning per share (EPS) of 7.59. IDEXX Laboratories had not issued any dividends in recent years. The entity had 2:1 split on the 16th of June 2015. Based on the key indicators related to IDEXX Laboratories' liquidity, profitability, solvency, and operating efficiency, IDEXX Laboratories is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.IDEXX Laboratories Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. IDEXX Laboratories has an asset utilization ratio of 122.59 percent. This implies that the Company is making €1.23 for each dollar of assets. An increasing asset utilization means that IDEXX Laboratories is more efficient with each dollar of assets it utilizes for everyday operations.IDEXX Laboratories Ownership Allocation
IDEXX Laboratories has a total of 82.9 Million outstanding shares. The majority of IDEXX Laboratories outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in IDEXX Laboratories to benefit from reduced commissions. Thereupon, third-party entities are subject to a different set of regulations than regular investors in IDEXX Laboratories. Please pay attention to any change in the institutional holdings of IDEXX Laboratories as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.IDEXX Laboratories Profitability Analysis
The company reported the revenue of 3.37 B. Net Income was 679.09 M with profit before overhead, payroll, taxes, and interest of 2 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates IDEXX Laboratories' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in IDEXX Laboratories and how it compares across the competition.
About IDEXX Laboratories Valuation
The stock valuation mechanism determines IDEXX Laboratories' current worth on a weekly basis. Our valuation model uses a comparative analysis of IDEXX Laboratories. We calculate exposure to IDEXX Laboratories's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of IDEXX Laboratories's related companies.IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine. IDEXX Laboratories operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 8000 people.
8 Steps to conduct IDEXX Laboratories' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates IDEXX Laboratories' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct IDEXX Laboratories' valuation analysis, follow these 8 steps:- Gather financial information: Obtain IDEXX Laboratories' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine IDEXX Laboratories' revenue streams: Identify IDEXX Laboratories' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research IDEXX Laboratories' industry and market trends, including the size of the market, growth rate, and competition.
- Establish IDEXX Laboratories' growth potential: Evaluate IDEXX Laboratories' management, business model, and growth potential.
- Determine IDEXX Laboratories' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate IDEXX Laboratories' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for IDEXX Stock analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |